BIP in Jämtland Härjedalen: Increased Access to CBT Within Regular Health Care in Northern Sweden (BIPBJÖRN)

October 3, 2023 updated by: Sarah Vigerland, Karolinska Institutet

Increased Access to Psychological Treatment for Children and Adolescents Through Internet-delivered CBT - a Pragmatic Evaluation Within Regular Health Care in a Rural Area of Sweden

The purpose of this study is to test internet-delivered cognitive behavior therapy for children and adolescents with anxiety disorders and obsessive-compulsive disorder in a routine clinical setting in a rural part of Sweden.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Aim The aim of this study is to conduct a pragmatic evaluation of ICBT for children and adolescents with anxiety disorders and OCD within routine health care in a rural area.

Research questions

  • Is ICBT an acceptable method for the patient group?
  • Is ICBT effective in a clinical setting?
  • Is further treatment needed after ICBT?
  • What are the long-term effects of ICBT?
  • What predicts treatment outcome?
  • How does ICBT work in a clincal setting? (time spent, negative effects etc)?

Design This is a uncontrolled intervention study where included families and children will be recruited consecutively during two years from a routine care CAMHS unit. All participants will be offered ICBT and assessed pre- and post-treatment, and at three-month follow-up through clinician ratings and self-report measures. The primary outcome measure is clinician rated severity of principal disorder at three-month follow-up. Long-term results will be assessed through study of medical records two years after completed ICBT.

Study Type

Interventional

Enrollment (Actual)

83

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Region Jämtland Härjedalen
      • Östersund, Region Jämtland Härjedalen, Sweden
        • BUP Jämtland Härjedalen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Fulfills diagnostic criteria for an anxiety disorder or OCD
  • Access to a computer and internet connection
  • Read and speak Swedish

Exclusion Criteria:

  • ICBT is currently not assessed to be a suitable treatment
  • Acute psychiatric problem (eg. severe depression or suicidality)
  • Current psychosocial problems in the family (i.e substance abuse, abuse, neglect)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ICBT
Therapist-supported internet-delivered CBT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CGI-S
Time Frame: 24 weeks from baseline
Clinical Global Impression - Severity
24 weeks from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CGI-S
Time Frame: 12 weeks from baseline
Clinical Global Impression - Severity
12 weeks from baseline
CGI-I
Time Frame: 12 and 24 weeks from baseline
Clinical Global Impression - Improvement
12 and 24 weeks from baseline
CGAS
Time Frame: 12 and 24 weeks from baseline
Children's Global Assessment Scale
12 and 24 weeks from baseline
CY-BOCS
Time Frame: 12 and 24 weeks from baseline
Children's Yale Brown Obsessive Compulsive Scale
12 and 24 weeks from baseline
RCADS
Time Frame: 12 and 24 weeks from baseline
Revised Children's Anxiety and Depression Scale
12 and 24 weeks from baseline
EWSAS
Time Frame: Week 1 through 12 + 24 weeks from baseline
Education, Work and Social Adjustment Scale - Child and parent versions
Week 1 through 12 + 24 weeks from baseline
Patient satisfaction
Time Frame: 12 weeks from baseline
Questionnaire on child- and parent rated treatment satisfaction
12 weeks from baseline
Adverse events
Time Frame: 12 weeks from baseline
Unintended treatment effects - child and parent version
12 weeks from baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eva Serlachius, Med Dr, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2016

Primary Completion (Actual)

April 1, 2019

Study Completion (Actual)

December 1, 2022

Study Registration Dates

First Submitted

September 20, 2016

First Submitted That Met QC Criteria

October 5, 2016

First Posted (Estimated)

October 6, 2016

Study Record Updates

Last Update Posted (Actual)

October 4, 2023

Last Update Submitted That Met QC Criteria

October 3, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • EPN DNR 2016/1355-31/5

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No such plan exists at the moment

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obsessive-Compulsive Disorder

Clinical Trials on ICBT

3
Subscribe